商务合作
动脉网APP
可切换为仅中文
NEW YORK – The American Cancer Society and Color Health plan to provide free at-home cancer screening, initially for colorectal cancer, starting in June, the Biden Cancer Moonshot initiative said this week. The two organizations plan to partner with federally qualified health centers and community health clinics to make colorectal cancer screening freely available, in particular to people with no or insufficient insurance.
纽约——拜登癌症登月计划本周表示,美国癌症协会和色彩健康计划将从6月开始提供免费的家庭癌症筛查,最初用于结直肠癌。这两个组织计划与联邦合格的卫生中心和社区卫生诊所合作,免费提供结直肠癌筛查,特别是对没有或没有足够保险的人。
Patients will receive a fecal immunochemical test (FIT) that looks for blood in the stool. Individuals will also have access to diagnostic follow-up through Color and ACS’s National Cancer Information Center. Going forward, the partners plan to add other cancer at-home screening tests. .
患者将接受粪便免疫化学测试(FIT),以寻找粪便中的血液。个人还可以通过Color和ACS国家癌症信息中心获得诊断随访。展望未来,合作伙伴计划在家中增加其他癌症筛查测试。。
Immunovia said this week that it plans to move its lab and US headquarters to Research Triangle Park in North Carolina. The move follows its announcement of positive results from a model development study for its pancreatic cancer detection test. Next steps include confirming the analytical validity of its new test and conducting a large clinical validation study, which will now take place at the firm’s new lab in Research Triangle Park.
Immunovia本周表示,它计划将其实验室和美国总部迁至北卡罗莱纳州的三角研究公园。此前,该公司宣布其胰腺癌检测试验模型开发研究的阳性结果。接下来的步骤包括确认其新测试的分析有效性,并进行一项大型临床验证研究,该研究将在该公司位于三角研究园的新实验室进行。
According to Immunovia, the decision to move locations is in line with a strategy it adopted in 2023 to streamline its operations and reduce costs. The new lab is significantly smaller than its prior space in Marlborough, Massachusetts. The firm also expects lower labor costs. .
Immunovia表示,搬迁地点的决定符合其在2023年采取的简化运营和降低成本的战略。新实验室比之前在马萨诸塞州马尔伯勒的空间要小得多。该公司还预计劳动力成本会降低。。
Becton Dickinson said this week that its board of directors has approved a quarterly dividend of $.95 per common share, payable on June 28 to holders of record as of June 10. The indicated annual dividend rate is $3.80 per share.
BectonDickinson本周表示,其董事会已批准每股普通股0.95美元的季度股息,于6月28日支付给截至6月10日的记录持有人。指定的年度股息率为每股3.80美元。
In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on GenomeWeb.
简而言之,本周精选了一些读者可能感兴趣但以前没有出现在GenomeWeb上的新闻。
最近内容 查看更多
新产品发布到GenomeWeb:Foundation Medicine,Cytek Biosciences,NimaGen,更多
1 天前
分子检测初创公司En Carta获得150万欧元种子前轮融资,用于莱姆病检测的开发
2024-05-22
人工智能工具在癌症治疗匹配中显示前景,但需要更多的训练数据
2024-05-21
相关公司查看更多
Immunovia
血液诊断产品研发商
产业链接查看更多
所属赛道